Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check6 days agoChange DetectedThe footer version label changes from v3.7.2 to v3.8.0, while the study record information remains unchanged.SummaryDifference0.1%

- Check13 days agoChange DetectedA notice was added announcing an NIH website transition and saying that “Super Intelligence” (SI) may appear in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.6%

- Check20 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe record history now shows Revision: v3.7.0, replacing the previous v3.6.6 entry. This indicates a new version of the page was published without altering the study content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study history page version was updated from v3.6.5 to v3.6.6, representing a new revision of the page. This update does not change the visible content.SummaryDifference0.1%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.